{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:36:45Z","timestamp":1778045805782,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00198-012-2230-4","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T15:49:19Z","timestamp":1353944959000},"page":"1529-1536","source":"Crossref","is-referenced-by-count":31,"title":["PTH replacement therapy of hypoparathyroidism"],"prefix":"10.1007","volume":"24","author":[{"given":"L.","family":"Rejnmark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sikjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Underbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mosekilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"2230_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00268-003-6903-1","volume":"28","author":"L Rosato","year":"2004","unstructured":"Rosato L, Avenia N, Bernante P, Palma M, Gulino G, Nasi PG, Pelizzo MR, Pezzullo L (2004) Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5\u00a0years. World J Surg 28:271\u2013276","journal-title":"World J Surg"},{"key":"2230_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jss.2010.03.059","volume":"163","author":"L Youngwirth","year":"2010","unstructured":"Youngwirth L, Benavidez J, Sippel R, Chen H (2010) Parathyroid hormone deficiency after total thyroidectomy: incidence and time. J Surg Res 163:69\u201371","journal-title":"J Surg Res"},{"key":"2230_CR3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00423-006-0097-6","volume":"392","author":"A Bergenfelz","year":"2007","unstructured":"Bergenfelz A, Jansson S, M\u00e5rtensson H, Reihn\u00e9r E, Wallin G, Kristoffersson A, Lausen I (2007) Scandinavian quality register for thyroid and parathyroid surgery: audit of surgery for primary hyperparathyroidism. Langenbecks Arch Surg 392:445\u2013451","journal-title":"Langenbecks Arch Surg"},{"key":"2230_CR4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/000313480407000204","volume":"70","author":"EA Mittendorf","year":"2004","unstructured":"Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70:114\u2013119","journal-title":"Am Surg"},{"key":"2230_CR5","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT, Brandi ML, Clarke BL, Shoback D, Juppner H, D\u2019Amour P, D\u2019Amour P, D\u2019Amour P, Fox J, Rejnmark L, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Dempster D, Gafni R, Collins MT, Collins MT, Sliney J, Sanders J (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target organ involvement, treatment, and challenges for future research. J Bone Miner Res 26:2317\u20132337","journal-title":"J Bone Miner Res"},{"key":"2230_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","volume":"8","author":"MR Pollak","year":"1994","unstructured":"Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG (1994) Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8:303\u2013307","journal-title":"Nat Genet"},{"key":"2230_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/hmg\/5.5.601","volume":"5","author":"J Baron","year":"1996","unstructured":"Baron J, Winer KK, Yanovski JA, Cunningham AW, Laue L, Zimmerman D, Cutler GB Jr (1996) Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 5:601\u2013606","journal-title":"Hum Mol Genet"},{"key":"2230_CR8","doi-asserted-by":"crossref","unstructured":"Christensen SE, Nissen PH, Vestergaard P, Mosekilde L (2011) Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes 18:359\u2013370","DOI":"10.1097\/MED.0b013e32834c3c7c"},{"key":"2230_CR9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","volume":"360","author":"S Watanabe","year":"2002","unstructured":"Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter\u2019s syndrome. Lancet 360:692\u2013694","journal-title":"Lancet"},{"key":"2230_CR10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/clinchem\/45.8.1347","volume":"45","author":"GR Mundy","year":"1999","unstructured":"Mundy GR, Guise TA (1999) Hormonal control of calcium homeostasis. Clin Chem 45:1347\u20131352","journal-title":"Clin Chem"},{"key":"2230_CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback D (2008) Hypoparathyroidism. N Engl J Med 359:391\u2013403","journal-title":"N Engl J Med"},{"key":"2230_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.1986.02140160057032","volume":"140","author":"F Santos","year":"1986","unstructured":"Santos F, Smith MJV, Chan JCM (1986) Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3) action of hydrochlorothiazide. Am J Dis Child 140:139\u2013142","journal-title":"Am J Dis Child"},{"key":"2230_CR13","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jc.87.7.3068","volume":"87","author":"K Sato","year":"2002","unstructured":"Sato K, Hasegawa Y, Nakae J, Nanao K, Takahashi I, Tajima T, Shinohara N, Fujieda K (2002) Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 87:3068\u20133073","journal-title":"J Clin Endocrinol Metab"},{"key":"2230_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00313910","volume":"232","author":"A Uncini","year":"1985","unstructured":"Uncini A, Tartaro A, Di SE, Gambi D (1985) Parkinsonism, basal ganglia calcification and epilepsy as late complications of postoperative hypoparathyroidism. J Neurol 232:109\u2013111","journal-title":"J Neurol"},{"key":"2230_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.1980.tb02725.x","volume":"12","author":"MB Forman","year":"1980","unstructured":"Forman MB, Sandler MP, Danziger A, Kalk WJ (1980) Basal ganglia calcification in postoperative hypoparathyroidism. Clin Endocrinol (Oxf) 12:385\u2013390","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2230_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","volume":"18","author":"BL Langdahl","year":"1996","unstructured":"Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P (1996) Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 18:103\u2013108","journal-title":"Bone"},{"key":"2230_CR17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","volume":"46","author":"MR Rubin","year":"2010","unstructured":"Rubin MR, Dempster DW, Kohler T, Stauber M, Zhou H, Shane E, Nickolas T, Stein E, Sliney J, Silverberg SJ, Bilezikian JP, M\u00fcller R (2010) Three dimensional cancellous bone structure in hypoparathyroidism. Bone 46:190\u2013195","journal-title":"Bone"},{"key":"2230_CR18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","volume":"22","author":"J Compston","year":"2011","unstructured":"Compston J (2011) Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int 22:2951\u20132961","journal-title":"Osteoporos Int"},{"key":"2230_CR19","unstructured":"Subramanian G, Fritton J, Quek S (2012) Osteonecrosis and atypical fractures\u2014common origins? Osteoporos Int. doi: 10.1007\/s00198\u2010012\u20101953\u20106"},{"key":"2230_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-152-5-201003020-00010","volume":"152","author":"L Wang","year":"2010","unstructured":"Wang L, Manson JE, Song Y, Sesso HD (2010) Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152:315\u2013323","journal-title":"Ann Intern Med"},{"key":"2230_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbiomolbio.2006.02.001","volume":"92","author":"A Zittermann","year":"2006","unstructured":"Zittermann A (2006) Vitamin D, and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92:39\u201348","journal-title":"Prog Biophys Mol Biol"},{"key":"2230_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","volume":"19","author":"T Shoji","year":"2004","unstructured":"Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1{alpha}-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179\u2013184","journal-title":"Nephrol Dial Transplant"},{"key":"2230_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","volume":"26","author":"TM Murray","year":"2005","unstructured":"Murray TM, Rao LG, Divieti P, Bringhurst FR (2005) Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 26:78\u2013113","journal-title":"Endocr Rev"},{"key":"2230_CR24","doi-asserted-by":"crossref","unstructured":"Gardella TJ, J\u00fcppner H (2001) Molecular properties of the PTH\/PTHrP receptor. Trends Endocrinol Metab 12:210\u2013217","DOI":"10.1016\/S1043-2760(01)00409-X"},{"key":"2230_CR25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0033-3182(99)71186-2","volume":"40","author":"PJ Velasco","year":"1999","unstructured":"Velasco PJ, Manshadi M, Breen K, Lippmann S (1999) Psychiatric aspects of parathyroid disease. Psychosomatics 40:486\u2013490","journal-title":"Psychosomatics"},{"key":"2230_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","volume":"146","author":"W Arlt","year":"2002","unstructured":"Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215\u2013222","journal-title":"Eur J Endocrinol"},{"key":"2230_CR27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","volume":"276","author":"KK Winer","year":"1996","unstructured":"Winer KK, Yanovski JA, Cutler GB Jr (1996) Synthetic human parathyroid hormone 1\u201334 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 276:631\u2013636","journal-title":"JAMA"},{"key":"2230_CR28","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jc.83.10.3480","volume":"83","author":"KK Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB Jr (1998) A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83:3480\u20133486","journal-title":"J Clin Endocrinol Metab"},{"key":"2230_CR29","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","volume":"88","author":"KK Winer","year":"2003","unstructured":"Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr (2003) Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1\u201334) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214\u20134220","journal-title":"J Clin Endocrinol Metab"},{"key":"2230_CR30","doi-asserted-by":"crossref","unstructured":"Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr (2008) Effects of once versus twice-daily parathyroid hormone1\u201334 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389\u20133395","DOI":"10.1210\/jc.2007-2552"},{"key":"2230_CR31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","volume":"95","author":"KK Winer","year":"2010","unstructured":"Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr (2010) Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1\u201334 versus calcitriol and calcium. J Clin Endocrinol Metab 95:2680\u20132688","journal-title":"J Clin Endocrinol Metab"},{"key":"2230_CR32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","volume":"97","author":"KK Winer","year":"2012","unstructured":"Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler GB (2012) Synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 97:391\u2013399","journal-title":"J Clin Endocrinol Metab"},{"key":"2230_CR33","doi-asserted-by":"crossref","unstructured":"Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT (2012) Daily parathyroid hormone 1\u201334 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811\u20131820","DOI":"10.1002\/jbmr.1627"},{"key":"2230_CR34","doi-asserted-by":"crossref","unstructured":"Rubin MR, Dempster DW, Sliney J, Zhou H, Nickolas TL, Stein EM, Dworakowski E, Dellabadia M, Ives R, McMahon DJ, Zhang C, Silverberg SJ, Shane E, Cremers S, Bilezikian JP (2011) PTH(1\u201384) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res 26:2727\u20132736","DOI":"10.1002\/jbmr.452"},{"key":"2230_CR35","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L, The Hypoparathyroid Study Group (2011) The effect of adding PTH (1\u201384) to conventional treatment of hypoparathyroidism\u2014a randomized, placebo controlled study. J Bone Miner Res 26:2358\u20132370","journal-title":"J Bone Miner Res"},{"key":"2230_CR36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","volume":"27","author":"T Sikjaer","year":"2012","unstructured":"Sikjaer T, Rejnmark L, Thomsen JS, Tietze A, Br\u00fcel A, Andersen G, Mosekilde L (2012) Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1\u201384): a randomized controlled study. J Bone Miner Res 27:781\u2013788","journal-title":"J Bone Miner Res"},{"key":"2230_CR37","doi-asserted-by":"crossref","unstructured":"Rubin M, Sliney J, McMahon D, Silverberg S, Bilezikian J (2010) Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int 21:1927\u20131934","DOI":"10.1007\/s00198-009-1149-x"},{"key":"2230_CR38","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1\u201334) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932\u20131941","journal-title":"J Bone Miner Res"},{"key":"2230_CR39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00223-011-9500-6","volume":"89","author":"B Jobke","year":"2011","unstructured":"Jobke B, Muche B, Burghardt A, Semler J, Link T, Majumdar S (2011) Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18\u00a0months. Calcif Tissue Int 89:130\u2013139","journal-title":"Calcif Tissue Int"},{"key":"2230_CR40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03008200802412462","volume":"50","author":"B Jobke","year":"2009","unstructured":"Jobke B, Pfeifer M, Minne HW (2009) Teriparatide following bisphosphonates: initial and long-term effects on microarchitecture and bone remodeling at the human iliac crest. Connect Tissue Res 50:46\u201354","journal-title":"Connect Tissue Res"},{"key":"2230_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bone.2008.09.019","volume":"44","author":"RR Recker","year":"2009","unstructured":"Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1\u201384. Bone 44:113\u2013119","journal-title":"Bone"},{"key":"2230_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/8756-3282(92)90203-9","volume":"13","author":"F Cosman","year":"1992","unstructured":"Cosman F, Schnitzer MB, McCann PD, Parisien MV, Dempster DW, Lindsay R (1992) Relationships between quantitative histological measurements and noninvasive assessments of bone mass. Bone 13:237\u2013242","journal-title":"Bone"},{"key":"2230_CR43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650020309","volume":"2","author":"SY Nottestad","year":"1987","unstructured":"Nottestad SY, Baumel JJ, Kimmel DB, Recker RR, Heaney RP (1987) The proportion of trabecular bone in human vertebrae. J Bone Miner Res 2:221\u2013229","journal-title":"J Bone Miner Res"},{"key":"2230_CR44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2131\/jts.37.617","volume":"37","author":"A Watanabe","year":"2012","unstructured":"Watanabe A, Yoneyama S, Nakajima M, Sato N, Takao-Kawabata R, Isogai Y, Sakurai-Tanikawa A, Higuchi K, Shimoi A, Yamatoya H, Yoshida K, Kohira T (2012) Osteosarcoma in Sprague\u2013Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1\u201334)). J Toxicol Sci 37:617\u2013629","journal-title":"J Toxicol Sci"},{"key":"2230_CR45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","volume":"34","author":"J Jolette","year":"2006","unstructured":"Jolette J, Wilker CE, Smith SY, Doyle N, Hardisty JF, Metcalfe AJ, Marriott TB, Fox J, Wells DS (2006) Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1\u201384 in a 2-year study in Fischer 344 rats. Toxicol Pathol 34:929\u2013940","journal-title":"Toxicol Pathol"},{"key":"2230_CR46","doi-asserted-by":"crossref","unstructured":"Karsdal MA, Qvist P, Christiansen C, Tank\u00f3 LB (2006) Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression? Drugs 66:1909\u20131918","DOI":"10.2165\/00003495-200666150-00002"},{"key":"2230_CR47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/157488611795684631","volume":"6","author":"T Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Mosekilde L (2011) PTH treatment in hypoparathyroidism. Curr Drug Saf 6:89\u201399","journal-title":"Curr Drug Saf"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2230-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2230-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2230-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T03:56:28Z","timestamp":1687838188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2230-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2230"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2230-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}